Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Anti‐PD‐1/CTLA‐4 bispecific antibody‐based combination therapy for cervical cancer: a multicenter study with biomarker analysis

Background Cadonilimab is a PD‐1/CTLA‐4 bispecific antibody with robust activity in platinum‐pretreated advanced cervical cancer, while its first‐line value and resistance mechanisms remain unclear. Methods This multicenter retrospective study enrolled 52 treatment‐naive patients with recurrent/metastatic cervical canc...

Ji-Wei Li, Yu-Ping Deng, Tao Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.